Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas
Paul A. Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2021) Vol. 192, Iss. 2, pp. 320-331
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Multiple spillovers from humans and onward transmission of SARS-CoV-2 in white-tailed deer
Suresh V. Kuchipudi, Meera Surendran Nair, Rachel M. Ruden, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 6
Open Access | Times Cited: 207
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 642-652
Open Access | Times Cited: 201
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy
Azizul Haque, Anudeep B. Pant
Journal of Autoimmunity (2022) Vol. 127, pp. 102792-102792
Open Access | Times Cited: 164
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e715-e725
Open Access | Times Cited: 140
Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study
Ingibjörg Magnúsdóttir, Anikó Lovik, Anna Bára Unnarsdóttir, et al.
The Lancet Public Health (2022) Vol. 7, Iss. 5, pp. e406-e416
Open Access | Times Cited: 140
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 134
COVID-19 vaccination and breakthrough infections in patients with cancer
Andrew Schmidt, Chris Labaki, Chih–Yuan Hsu, et al.
Annals of Oncology (2021) Vol. 33, Iss. 3, pp. 340-346
Open Access | Times Cited: 94
Analysis of the ARTIC Version 3 and Version 4 SARS-CoV-2 Primers and Their Impact on the Detection of the G142D Amino Acid Substitution in the Spike Protein
James J. Davis, S. Wesley Long, Paul A. Christensen, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 70
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
Pedro F.N. Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, et al.
International Journal of Biological Macromolecules (2022) Vol. 208, pp. 105-125
Open Access | Times Cited: 59
Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics.
Noosha Samieefar, Ronak Rashedi, Meisam Akhlaghdoust, et al.
PubMed (2022) Vol. 93, Iss. 1, pp. e2022179-e2022179
Closed Access | Times Cited: 47
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study
Miguel Garcia-Knight, Khamal Anglin, Michel Tassetto, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010802-e1010802
Open Access | Times Cited: 46
Clinical grade ACE2 as a universal agent to block SARS‐CoV ‐2 variants
Vanessa Monteil, Brett Eaton, Elena Postnikova, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 8
Open Access | Times Cited: 45
Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China
Zhiliang Hu, Bilin Tao, Zhongqi Li, et al.
International Journal of Infectious Diseases (2022) Vol. 116, pp. 204-209
Open Access | Times Cited: 40
Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
Rupsha Fraser, Aurelio Orta‐Resendiz, Alexander Mazein, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 255-267
Open Access | Times Cited: 31
CRISPR techniques and potential for the detection and discrimination of SARS-CoV-2 variants of concern
Huyan Xiao, Jianyu Hu, Camille Huang, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 161, pp. 117000-117000
Open Access | Times Cited: 21
Control of airborne infectious disease in buildings: Evidence and research priorities
P. Jacob Bueno de Mesquita, William W. Delp, Wanyu R. Chan, et al.
Indoor Air (2021) Vol. 32, Iss. 1
Open Access | Times Cited: 43
Controlling Multiple COVID-19 Epidemic Waves: An Insight from a Multi-scale Model Linking the Behaviour Change Dynamics to the Disease Transmission Dynamics
Biao Tang, Weike Zhou, Xia Wang, et al.
Bulletin of Mathematical Biology (2022) Vol. 84, Iss. 10
Open Access | Times Cited: 35
Detection of SARS-CoV-2 Omicron variant (B.1.1.529) infection of white-tailed deer
Kurt J. Vandegrift, Michele Yon, Meera Surendran Nair, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Clinical manifestations of COVID‐19 breakthrough infections: A systematic review and meta‐analysis
Christine J. Lee, Wongi Woo, Ah Young Kim, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4234-4245
Open Access | Times Cited: 31
SARS-CoV-2 Omicron (B.1.1.529) Infection of Wild White-Tailed Deer in New York City
Kurt J. Vandegrift, Michele Yon, Meera Surendran Nair, et al.
Viruses (2022) Vol. 14, Iss. 12, pp. 2770-2770
Open Access | Times Cited: 31
Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis
Cong Liu, Junghwan Lee, Casey Ta, et al.
JMIR Public Health and Surveillance (2022) Vol. 8, Iss. 5, pp. e35311-e35311
Open Access | Times Cited: 27
An overview of SARS-CoV-2 transmission and engineering strategies to mitigate risk
Bey Fen Leo, Chin Yik Lin, Kalaimani Markandan, et al.
Journal of Building Engineering (2023) Vol. 73, pp. 106737-106737
Open Access | Times Cited: 19
SARS-CoV-2 niches in human placenta revealed by spatial transcriptomics
Enrico R. Barrozo, Maxim D. Seferovic, Eumenia Castro, et al.
Med (2023) Vol. 4, Iss. 9, pp. 612-634.e4
Open Access | Times Cited: 16
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine
İsmail Yılmaz, Emre Mert İpekoğlu, Berfu Saraydar Golcuklu, et al.
Vaccine (2025) Vol. 49, pp. 126787-126787
Closed Access
Page 1 - Next Page

Scroll to top